IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 118 filers reported holding IMMUNOVANT INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,473,032 | -62.2% | 142,564 | -81.3% | 0.01% | -60.0% |
| Q2 2023 | $14,478,113 | +110.0% | 763,211 | +71.7% | 0.02% | +114.3% |
| Q1 2023 | $6,893,466 | +30.1% | 444,453 | +48.9% | 0.01% | +16.7% |
| Q4 2022 | $5,297,843 | +2944.7% | 298,470 | +1365.2% | 0.01% | – |
| Q4 2021 | $174,000 | -56.8% | 20,371 | -18.9% | 0.00% | – |
| Q1 2021 | $403,000 | – | 25,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |